Vapotherm(R) Launches New Device, Precision Flow(TM)

    STEVENSVILLE, Md., Nov. 29 /PRNewswire-USNewswire/ -- Vapotherm, the
 global leader in High Flow Oxygen Therapy products, will introduce a new
 respiratory care device at the AARC annual conference in Orlando, Florida
 on December 1, 2007. Vapotherm's Precision Flow(TM) is the first high flow
 therapy device to integrate humidification, gas blending, flow control, and
 full alarm functionality into a single device for the delivery of nasal
 cannula inspired gases. The company has submitted and is awaiting 510(k)
 clearance for the new product from the FDA.
 
 
 
     "Vapotherm literally established the High Flow Oxygen Therapy category
 and the launch of Precision Flow(TM) not only reinforces our leadership
 role in the industry but also illustrates our dedication to developing
 innovative respiratory devices that help healthcare professionals improve
 the quality of life for their patients," said Robert Storey, President and
 CEO of Vapotherm. "The AARC meeting is the ideal venue for us to introduce
 the new technology and get valuable feedback from the respiratory
 community."
 
 
 
     The company's current device, the 2000i, is used in hundreds of
 hospitals throughout the US. With Precision Flow(TM), the respiratory
 community will have a new option in high flow therapy that includes broader
 functionality, additional safety features and ease of use. "We developed
 Precision Flow(TM) with extensive input from our respiratory customers and
 we believe the device will meet their stated requirements for performance,
 safety and cost-effectiveness," said Kevin Thibodeau, Vice President of
 Sales and Marketing.
 
 
 
     Precision Flow(TM) will be unveiled by Vapotherm at Booth #1337 during
 the AARC annual conference in Orlando, Florida in December. The device is
 pending FDA 510(k) clearance and is not currently available for sale in the
 US.
 
 
 
     Vapotherm, Inc. is a privately held manufacturer of respiratory care
 devices for hospitals and home care use based in Stevensville, Maryland.
 The Company is dedicated to the development of innovative, noninvasive
 technologies for respiratory therapy, especially for the treatment of
 chronic lung and acute breathing disorders. For more information, visit
 www.vtherm.com.
 
 
 
     CONTACT:
 
     Amy Elias/Brian Johnson
 
     Profiles, Inc.
 
     410-243-3790
 
     amy@profilespr.com
 
     brian@profilespr.com
 
 
 
 
 

SOURCE Vapotherm, Inc.